Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015

This study uses Medicare Part D drug utilization and spending data to estimate potential Part D program and beneficiary savings on brand-name medications excluded by pharmacy benefit managers for which generic substitutes are available.

Saved in:
Bibliographic Details
Published in:JAMA Intern Med
Main Authors: Egilman, Alexander C., Wallach, Joshua D., Ross, Joseph S., Dhruva, Sanket S.
Format: Artigo
Language:Inglês
Published: American Medical Association 2018
Subjects:
Research Letter
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5876838/
https://ncbi.nlm.nih.gov/pubmed/29340562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2017.8016
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items